Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Clinical trial NCT01028716 · TERMINATED

Trial details

NCT number: NCT01028716
Sponsor: Fred Hutchinson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Biphenotypic Leukemia Acute Erythroid Leukemia in Remission Acute Leukemia in Remission Acute Lymphoblastic Leukemia in Remission Acute Myeloid Leukaemia With Prior Myelodysplastic Syndrome Acute Myeloid Leukemia in Remission Acute Myeloid Leukemia With FLT3/ITD Mutation Acute Myeloid Leukemia With Inv(3)(Q21Q26.2); RPN1-EVI1 Acute Myeloid Leukemia With Multilineage Dysplasia Acute Myeloid Leukemia With t(6;9)Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Complete Remission

Start date: 2010-05-19
Primary completion: 2021-10-07
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.